Alleroff
NDC Package 16853-1307-2
Package Information
Alleroff is a medication used as UsesTemporarily relieves these symptoms due to hay fever or other upper respiratory allergies:Runny NoseItchy,water eyesItching of the nose or throatSneezing. Marketed by Corporacion Infarmasa, this product is identified by NDC 16853-1307 and is authorized under FDA application NDA019835.
Identification & Billing
- RxCUI: 1014678 - cetirizine HCl 10 MG Oral Tablet
- RxCUI: 1014678 - cetirizine hydrochloride 10 MG Oral Tablet
- RxCUI: 1020025 - Alleroff 10 MG Oral Tablet
- RxCUI: 1020025 - cetirizine hydrochloride 10 MG Oral Tablet [Alleroff]
- RxCUI: 1020025 - Alleroff (cetirizine dihydrochloride 10 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16853 - Corporacion Infarmasa
- 16853-1307 - Alleroff
- 16853-1307-2 - 3 BLISTER PACK in 1 BOX / 10 TABLET in 1 BLISTER PACK (16853-1307-1)
- 16853-1307 - Alleroff
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16853-1307-2 identifies a specific commercial package of 3 blister pack in 1 box / 10 tablet in 1 blister pack (16853-1307-1) of Alleroff, labeled by Corporacion Infarmasa. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Corporacion Infarmasa on January 01, 2010. The current certification is valid through December 31, 2017.
How is this Corporacion Infarmasa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16853130702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.